• October 16, 2008
• October 6, 2008
• Sep. 29, 2008
• Sep. 4, 2008
• August 27, 2008
• August 21, 2008
• August 13, 2008
• August 4, 2008

SoCalBio Networking Forum in Orange County

 

• Chris Robertson, PharmD, Product Development Team Leader, Kythera Biopharmaceuticals, Inc.
• Max Sidner, U.S. Agent, Vincent Medical Mfg. Co., Ltd

• Despite Financial Turmoil, Biotechs Still Able to Secure Venture Capital in Q3/08

Data released by two trackers of VC market trends also showed that medical device investment is harder to glean, and that the San Francisco Bay Area extended its dominance as the nation's largest cluster for both biotech and medical devices, both by dollars raised and numbers of deals .. Read article 

• Investors Turn to Pharma for Yields

Everyone is looking for a safer place to put their money these days, and that means analysts and stock-pickers are paying closer attention to Big Pharma. Seeking Alpha prepared a list of the top ten highest yielding pharma stocks ... See list

• InformationTechnology Advances Will Spur Outsourcing & Improve Efficiencies

The Wall Street Journal looks at four ways that information technology soon will alter how the health care industry conducts its business. The newspaper predicts a move to outsourced diagnostic services, improved efficiencies through greater integration of information systems, global monitoring of drug safety and improvements in the quality of information that doctors and patients receive ... Read article 

• Booz & Company Study Finds U.S. Leading in R&D Spending

Booz & Co. has crunched the numbers on the 1,000 largest public R&D spenders and concluded that the U.S. still is way out in front among all the countries of the world for research. But the analysis also notes that while India and China are still relatively small players on the R&D front, they're growing fast. And 22 cents out of every R&D buck is being used for research related to health ... Read Press release

Local Company Headlines

• Amgen (Thousand Oaks, CA): 
  • Denosumab strengthens Amgen amid frail market
• Calando Pharmaceuticals Inc. (Pasadena, CA)
  • Arrowhead CEO Provides Update on Majority Owned Subsidiary Calando Pharmaceuticals Inc.
• Cougar Biotechnology (Los Angeles, CA)
  • Positive Phase II Data on Cougar Biotechnology's CB7630 Presented at Prostate Cancer Foundation Scientific Retreat
• Endologix (Irvine, CA)
  • Endologix Announces FDA Approval of Powerlink XL System for the Treatment of Abdominal Aortic Aneurysms in Patients with Large Aortic Necks
• Masimo (Irvine, CA)
  • Five New Clinical Studies Show Value of Masimo PVI & PI 
• Valeant Pharmaceuticals (Aliso Viejo), CA)
  • Valeant gets $125M from deal with Glaxo

 

• Bioscience Firms in Gold Coast (Ventura and Santa Barbara Counties)
• Bioscience Firms in Los Angeles County
• Bioscience Firms in Orange County
• Bioscience Firms in Inland Empire (Riverside and San Bernardino Counties)

• Alfred Mann Foundation for Biomedical Engineering (Valencia, CA):

Sr. Market Analyst - Regular, Full-Time or Part-Time:  Experienced & proven medical device marketing professional.  The primary responsibilities include market research and analysis on emerging medical devices to support the allocation of significant financial resources to fund development activities. Analyze markets & clinical technology areas through robust due diligence, understand the differences in global market trends in biomedical technologies and determine the product specifications required to address market needs.  BS or MBS and 5 years of experience. Click to send resume